Literature DB >> 15933870

Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease.

Yasushi Iwasaki1, Yoshio Hashizume, Mari Yoshida, Tetsuyuki Kitamoto, Gen Sobue.   

Abstract

We investigated whether the brainstem is affected by the pathologic process of sporadic Creutzfeldt-Jakob disease (sCJD), with particular attention to brainstem atrophy, neuronal loss, pyramidal tract degeneration, and prion protein (PrP) deposition, in 33 patients with sCJD. Brainstem atrophy, particularly in the pontine base, was relatively prominent in patients with disease of unusually prolonged duration. Neuronal loss and pyramidal tract degeneration were also identified in some but not all patients with prolonged disease. Neuronal loss was relatively prominent in the pontine nucleus and less so in the substantia nigra and inferior olivary nucleus; motor nuclei of the brainstem tegmentum were well preserved. PrP deposition was present in the brainstem in all patients, and was identified predominantly in the substantia nigra, quadrigeminal body, pontine nucleus, and inferior olivary nucleus. PrP deposition was less prominent in the red nucleus and tegmentum of the pons and medulla oblongata. PrP deposition occurred least or not at all in the pyramidal tract. The density of PrP deposition in the sCJD brainstem was not associated with disease duration or neuronal degeneration until the late stage. Our results show that atrophy, neuronal loss, and pyramidal tract degeneration occur in the sCJD brainstem, particularly in patients with an unusually prolonged disease course. These findings are not associated directly with PrP deposition and may reflect end-stage sCJD. No VV1, VV2, or MV2 cases were included in our study; however, we suggest that widespread and relatively stereotypic PrP deposition is a consistent pathologic feature of sCJD, at least in MM1 sCJD patients. Although accumulation of PrP in the brainstem appears to be an early pathologic event in sCJD, and may remain into the late disease stage, the brainstem remains relatively resistant to the pathologic process of sCJD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933870     DOI: 10.1007/s00401-005-0981-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Familial Creutzfeldt-Jakob disease with E200K mutation presenting with neurosensorial hypoacusis.

Authors:  R Reñé; J Campdelacreu; I Ferrer; A Escrig; M Povedano; J Gascón-Bayarri; E Moral
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

2.  Familial Creutzfeldt-Jakob disease with E200K mutation presenting with neurosensorial hypoacusis.

Authors:  R Reñé; J Campdelacreu; I Ferrer; A Escrig; M Povedano; J Gascón-Bayarri; E Moral
Journal:  BMJ Case Rep       Date:  2009-07-07

3.  An autopsy-verified case of FTLD-TDP type A with upper motor neuron-predominant motor neuron disease mimicking MM2-thalamic-type sporadic Creutzfeldt-Jakob disease.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Akira Takekoshi; Nobuaki Yoshikura; Takahiko Asano; Maya Mimuro; Akio Kimura; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takashi Inuzuka
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

4.  Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation.

Authors:  Akio Akagi; Yasushi Iwasaki; Maya Mimuro; Tetsuyuki Kitamoto; Masahito Yamada; Mari Yoshida
Journal:  Prion       Date:  2018-01-31       Impact factor: 3.931

5.  An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Nobuaki Yoshikura; Takahiko Asano; Maya Mimuro; Akio Kimura; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takashi Inuzuka
Journal:  Prion       Date:  2017-07-27       Impact factor: 3.931

6.  Creutzfeldt-Jakob disease presenting with bilateral hearing loss: A case report.

Authors:  Seunghee Na; Se A Lee; Jong Dae Lee; Eek-Sung Lee; Tae-Kyeong Lee
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

7.  At the centre of neuronal, synaptic and axonal pathology in murine prion disease: degeneration of neuroanatomically linked thalamic and brainstem nuclei.

Authors:  Renata Reis; Edel Hennessy; Caoimhe Murray; Éadaoin W Griffin; Colm Cunningham
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-30       Impact factor: 8.090

8.  Identification of clinical target areas in the brainstem of prion-infected mice.

Authors:  Ilaria Mirabile; Parmjit S Jat; Sebastian Brandner; John Collinge
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04-23       Impact factor: 8.090

9.  Sporadic Creutzfeldt-Jakob Disease: Prion Pathology in Medulla Oblongata-Possible Routes of Infection and Host Susceptibility.

Authors:  Diego Iacono; Sergio Ferrari; Matteo Gelati; Gianluigi Zanusso; Sara Mariotto; Salvatore Monaco
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

10.  Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia.

Authors:  Koji Fujita; Naoko Matsui; Yukitoshi Takahashi; Yasushi Iwasaki; Mari Yoshida; Tatsuhiko Yuasa; Yuishin Izumi; Ryuji Kaji
Journal:  J Neuroinflammation       Date:  2013-11-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.